MedTrace Logo

Implementing an Evidence-based Computerized Decision Support System Linked to Electronic Health Records to Improve Care for Cancer Patients

NCT02645357 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15431

Last updated 2017-02-09

No results posted yet for this study

Summary

Implementing an evidence-based computerized decision support system linked to electronic health records to improve care for cancer patients.

The ONCO-CODES (Computerized DEcision Support in ONCOlogy) trial is a pragmatic, parallel group, randomized controlled study with 1:1 allocation ratio Study Duration 12 month Study Center(s) Single-center

Objectives:

The primary outcome of this trial is a process outcome. i.e. the rate at which the issues reported by the reminders are resolved (resolution rates).

Conditions

  • Medical Oncology

Interventions

OTHER

computer reminders on clinical practice

on-screen, point-of-care computer reminders on clinical practice.

OTHER

Control group

control group

Sponsors & Collaborators

  • Ministry of Health, Italy

    collaborator OTHER_GOV

  • University of Milan

    collaborator OTHER

  • I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

    collaborator OTHER

  • Catholic University of the Sacred Heart

    collaborator OTHER

  • Duodecim, Finnish Medical Association, Helsinki

    collaborator UNKNOWN

  • Mario Negri Institute for Pharmacological Research

    collaborator OTHER

  • Ottawa Hospital Research Institute

    collaborator OTHER

  • Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

    lead OTHER

Principal Investigators

  • Alessandro Passardi, MD · IRST IRCCS

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-12-31
Completion
2017-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02645357 on ClinicalTrials.gov